“…Although this meta-analysis did not show the significant association between XRCC3 rs861539 polymorphism and oral cancer risks, the present results also provided new evidence for the susceptibility and etiology of oral cancer. In recent years, there are some meta-analyses about XRCC3 polymorphisms and cancer risks, which comprised breast cancer, cervical cancer, colorectal cancer, gliomas and head and neck caner published in the journal Asian Pac J Cancer Prev and the results are not concordant, suggesting this polymorphism plays different role in diverse types of cancer (Yin et al, 2012;Jiang et al, 2013;Nassiri et al, 2013;Qin et al, 2013;Mao et al, 2014). It is well known that systematic review and meta-analyses are considered the highest level of evidence in Evidencebased Medicine.…”